Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
Neurology
.
2024 May 14;102(9):e209375.
doi: 10.1212/WNL.0000000000209375.
Epub 2024 Apr 22.
Authors
Paolo Salvioni Chiabotti
1
,
Olivier Rouaud
1
,
Gilles Allali
1
Affiliation
1
(Lausanne, Switzerland).
PMID:
38648577
DOI:
10.1212/WNL.0000000000209375
No abstract available
Publication types
Letter
MeSH terms
Aged
Alzheimer Disease / drug therapy
Amyloid beta-Peptides
Cognitive Aging* / physiology
Humans
Substances
Amyloid beta-Peptides